“…They appear between 2 days and 3 weeks from the start of treatment, regressing spontaneously without scarring or sequelae 1 to 4 weeks after the suspension of the drug. [24][25][26][27][28] The differential diagnosis is vast and includes: sepsis, septic embolism in a post-chemotherapeutic neutropenic patient, vasculitis, leukemia cutis, hypersensitivity reaction, urticaria, polymorphous erythema, and neutrophilic dermatoses such as Sweet's syndrome, bullous pyoderma gangrenosum and atypical pyoderma gangrenosum. 18,28,29 Due to the unspecific clinical presentation of the disease and the great number of differential diagnoses, some authors suggest that NEH be included in the diagnostic hypotheses of any eruption that may occur in patients undergoing chemotherapy, and its final diagnosis is established via histopathology.…”